FDA seeking to lower the classification of electroshock therapy from class III to class II (Audio)
03/24/2016 / By Martin Mavis
Topic is the FDA seeking to lower the classification of electroshock therapy from class III to class II. Two guests explain the ramifications of this effort by the FDA . Dr John Breeding, Ph.D He’s a psychologist with for over 25 years of experience . Dr. Breeding is the author of four books. Joining the conversation is Lee Spiller from Citizens Commission on Human Rights Texas. CCHR Texas functions solely as a mental health watchdog organization.
Tagged Under: classification, electroshock, FDA, therapy
RECENT NEWS & ARTICLES
